Is immuno-oncology360.org Safe? Security Analysis for The Conference Forum
https://immuno-oncology360.orgCheck if immuno-oncology360.org is a scam or legitimate. Free security scan and reviews.
Below Healthcare avg (65)
10,000+
Domains scanned
500+
Security teams trust us
EveryPay
Secure checkout
Instant
Reports delivered
Get the professional PDF report for immuno-oncology360.org
Export this security analysis as a professional PDF document, receive it via email, and access marketing intelligence data including contact emails and phone numbers. One-time purchase for lifetime access.
PDF Report & Export
PDF download, email delivery, unlock code
Marketing Intelligence
Contact emails, phone numbers & warm leads
Plan Comparison
| Feature | PDF Report | Marketing+ |
|---|---|---|
| Full security analysis | ||
| Professional PDF export | ||
| Email delivery | ||
| Lifetime access + unlock code | ||
| Contact emails & phones | — | |
| Marketing outreach data | — |
Already purchased?
Order summary
Digital reports are delivered immediately after payment. By continuing you acknowledge the withdrawal waiver described in our Returns & Refunds policy.
Secure payments processed via EveryPay. Prices in EUR; Incl. 21% VAT.
SEQ SIA
Lastadijas 12 k-3, Riga, Latvia, LV-1050
Reg. No. 40203410806 • VAT LV40203410806
Support: guard@offseq.com • +371 2256 5353
AI Summary
Immuno-Oncology360.org is a specialized digital platform operated by The Conference Forum, focusing on the Immuno-Oncology and Cell Therapy sector. It offers a comprehensive suite of services including conferences, editorial content, podcasts, webinars, and marketing services tailored to healthcare professionals and biotech industry stakeholders. The platform positions itself as a niche leader in this healthcare segment, supporting community engagement and knowledge sharing. Technically, the website employs a modern technology stack with popular JavaScript libraries and tracking tools, hosted on Amazon AWS infrastructure with Cloudfront CDN, ensuring moderate performance and good mobile optimization. Security posture is adequate with HTTPS enforced and client domain protections enabled, but lacks DNSSEC and explicit security headers, and does not publish formal security or incident response policies. Privacy compliance is basic, with a privacy policy present but no cookie consent mechanism detected. Overall, the site is professional, trustworthy, and content-rich, suitable for its target audience but with room for security and privacy improvements.
Detected Technologies
11 urgent findings need attention
1 critical · 10 high
- + 3 more findings in the full report below
Keep immuno-oncology360.org under constant watch
Guard tracks your live infrastructure daily: certificate expiry, DNS & mail authentication drift, uptime changes, subdomain inventory, and unexpected tracker or content shifts. A full timeline captures every diff so you can prove remediation and spot regressions instantly.
Security drift alerts
Risk score drops, new high-severity issues, and header hardening gaps
Compliance watch
GDPR / NIS2 posture changes with governance evidence snapshots
Infrastructure surface
Unexpected open services, SSL expiry, DNS & email authentication changes
Content & tracker intelligence
Marketing tech shifts, analytics drift, and AI recommendation updates
Cancel anytime. Alerts sent to the contacts you choose. Unlock the full report to view historical timelines and alerts.
Security Headers
7 findings
20/100
GDPR Compliance
4 findings
53/100
NIS2 Compliance
8 findings
17/100
Email Security
5 findings
60/100
🧠AI Business Intelligence
Technology stack, business insights, and market analysis powered by AI.
Business Intelligence
Market & Strategic Analysis
The Conference Forum operates immuno-oncology360.org as part of a broader ecosystem of healthcare and biotech conference and content platforms. The business model centers on event organization, content publishing, and marketing services, generating revenue through conferences and sponsored content. The platform targets healthcare professionals, researchers, and biotech companies interested in Immuno-Oncology and Cell Therapy. Its market position is that of a specialized niche leader with a growing presence since its recent 2024 launch. Partnerships with related domains and event sites strengthen its ecosystem. The absence of direct contact emails or phone numbers suggests a controlled communication channel primarily via web forms. The platform demonstrates digital maturity with integrated analytics and marketing tools, supporting growth and audience engagement.
Security Posture Analysis
Comprehensive Security Assessment
The website demonstrates a moderate security maturity level. HTTPS is properly implemented, and domain registrar protections such as clientDeleteProhibited are enabled, reducing risk of unauthorized domain changes. However, the lack of DNSSEC and missing security headers like Content-Security-Policy and X-Frame-Options represent gaps that could expose the site to certain attacks. The use of Google reCAPTCHA on forms is a positive control against automated abuse. No explicit security or incident response policies are published, which limits transparency and preparedness perception. Privacy compliance is partial, with a privacy policy present but no cookie consent mechanism, potentially exposing the site to GDPR compliance risks. Overall, the security posture is adequate for a content and event platform but would benefit from enhanced technical controls and policy disclosures.
Strategic Recommendations
Priority Actions for Security Improvement
Enable DNSSEC on the domain to improve DNS security and prevent spoofing.
✨Observations
AI-powered comprehensive website and business analysis.
AI-Enhanced Website Analysis
Business Insights
The Conference Forum
A platform serving the Immuno-Oncology and Cell Therapy community providing conferences, editorial content, podcasts, webinars, and marketing services.
good
consistent
Technical Stack
moderate
good
basic
good
Security Assessment
- HTTPS enforced
- Use of reCAPTCHA on forms
- Domain status client protections enabled
Analytics & Tracking
Advertising & Marketing
Website Quality Assessment
Key Observations
Website is a professional platform focused on Immuno-Oncology and Cell Therapy community.
Get this report delivered to your inbox
Receive a summary of the immuno-oncology360.org security findings by email. Quick and easy to share with decision makers.
🛡️Security Headers
HTTP security headers analysis and recommendations.
Security Headers
HTTP security headers analysis
Missing Strict-Transport-Security header
HIGHForces HTTPS connections
Missing X-Frame-Options header
HIGHPrevents clickjacking attacks
Missing X-Content-Type-Options header
MEDIUMPrevents MIME type sniffing
Missing Content-Security-Policy header
HIGHControls resources the browser is allowed to load
Missing X-XSS-Protection header
MEDIUMLegacy XSS protection (deprecated but still recommended)
Missing Referrer-Policy header
LOWControls referrer information sent with requests
Missing Permissions-Policy header
MEDIUMControls browser features and APIs
👤GDPR Compliance
Privacy and data protection assessment under GDPR regulations.
GDPR Compliance
Privacy and data protection assessment
No Cookie Policy found
HIGHGDPR requires clear information about cookie usage
No Cookie Consent Banner found
HIGHGDPR requires explicit consent for non-essential cookies
No Data Protection Officer mentioned
LOWLarge organizations may need to designate a DPO under GDPR
Privacy policy may not be GDPR compliant
MEDIUMPrivacy policy lacks explicit GDPR compliance elements
GDPR Compliance Analysis
🛡️NIS2 Compliance
Network & Information Security Directive compliance assessment.
NIS2 Compliance
Network & Information Security Directive
No information security framework found
HIGHNIS2 requires documented cybersecurity and information security measures
No vulnerability disclosure policy
MEDIUMNIS2 encourages coordinated vulnerability disclosure
No security policy documentation found
HIGHNIS2 requires documented cybersecurity governance and risk management
No incident response procedures found
HIGHNIS2 requires documented incident response and business continuity plans
No business continuity planning found
MEDIUMNIS2 emphasizes operational resilience and business continuity
No security contact information
HIGHNIS2 requires clear incident reporting channels
No vulnerability reporting mechanism
MEDIUMClear vulnerability reporting supports coordinated disclosure
No NIS2 reference found
LOWConsider explicitly mentioning NIS2 compliance efforts
Need this report as a PDF?
Download the complete immuno-oncology360.org security analysis as a professional PDF. Share it with your team, clients, or stakeholders.
📧Email Security
SPF, DKIM, and DMARC validation and email security assessment.
Email Security
SPF, DKIM, and DMARC validation
No DKIM record found
MEDIUMDKIM adds cryptographic signatures to emails
No BIMI Record
LOWBIMI displays brand logos in email clients
No MTA-STS Policy
MEDIUMMTA-STS enforces TLS for email delivery
No TLS-RPT Record
LOWTLS-RPT provides reporting for email TLS issues
No email authentication configured
CRITICALDomain is vulnerable to email spoofing
🏆SSL/TLS Security
Certificate validity and encryption analysis.
SSL/TLS Security
Certificate validity and encryption analysis
Weak Protocols Supported
HIGHServer supports weak protocols: TLSv1.1
OCSP Stapling Not Enabled
LOWOCSP stapling improves performance and privacy
Certificate Transparency Not Implemented
LOWCertificate is not logged in Certificate Transparency logs
Partial SSL/TLS Assessment
LOWCompleted 3 of 4 security checks due to time constraints
Protocol Support
OCSP Status
📊DNS Health
DNS configuration and security assessment.
DNS Health
DNS configuration and security assessment
DNSSEC Not Enabled
MEDIUMDNSSEC is not configured for this domain
CAA Records Not Configured
LOWCertificate Authority Authorization (CAA) records not found
No DMARC Record
MEDIUMDMARC policy not configured
Domain Registration Details
DNS Records
DNSSEC Status
DNS Performance
⚡Network Security
Port scanning and network exposure analysis.
Network Security
Port scanning and network exposure analysis
Good Network Security Posture
LOWNo unnecessary services detected on common risky ports
How does immuno-oncology360.org compare?
See how immuno-oncology360.org stacks up against similar websites in the same industry.
🔧Technical Analysis
Detailed technical findings and analysis from AI assessment.
Technical Analysis
Comprehensive security assessment findings
Additional Findings
Download the immuno-oncology360.org report as PDF
Get the complete analysis in a shareable PDF format, delivered instantly to your email with lifetime access.
PDF Report & Export
PDF download, email delivery, unlock code
Marketing Intelligence
Contact emails, phone numbers & warm leads
Plan Comparison
| Feature | PDF Report | Marketing+ |
|---|---|---|
| Full security analysis | ||
| Professional PDF export | ||
| Email delivery | ||
| Lifetime access + unlock code | ||
| Contact emails & phones | — | |
| Marketing outreach data | — |
Already purchased?
Order summary
Digital reports are delivered immediately after payment. By continuing you acknowledge the withdrawal waiver described in our Returns & Refunds policy.
Secure payments processed via EveryPay. Prices in EUR; Incl. 21% VAT.
SEQ SIA
Lastadijas 12 k-3, Riga, Latvia, LV-1050
Reg. No. 40203410806 • VAT LV40203410806
Support: guard@offseq.com • +371 2256 5353
Scan your own website
Liked the immuno-oncology360.org report? Run the same comprehensive security analysis on your domain — free, instant, and no sign-up required.
Or browse our directory of >10,000 scanned websites.
How did we do?
Your feedback directly shapes our roadmap. Rate the quality of this report, leave an optional comment, and let us know if you want our security specialists to follow up.
What others say about immuno-oncology360.org
Share your experience to help others make informed decisions. We verify every review by email and publish it once our moderation team approves it.
Community rating
—out of 5
0 reviews published